Background. Matrix metalloproteinases (MMPs) play a key role in oxidative stress, circulatory metabolism, and pro- and anti-inflammatory conditions during the progression of SARS-CoV-2 infection. Protease activity dysregulation brought on by the inflammatory response could be connected to complications following COVID-19. Aberrant MMP function may show up in the blood and harm the blood’s proteolytic processes in post-COVID-19 period.
The aim of our research to determine the quantitative levels MMP-1, -2, -3, -8, -9, -10 in blood plasma of donor groups depending on titers of anti-SARS-CoV-2 IgG.
Materials and methods. People who had suffered from COVID-19 agreed to be donors of blood plasma for biotechnological purposes at the "BIOPHARMA-PLASMA" company (Kyiv, Ukraine). Blood plasma was collected from donors who had recovered from COVID-19 3-6 months ago. We had donor groups with anti-SARS-CoV-2 IgG titers (20 donors in each group): 0, 10 ± 3, 55 ± 5, 65 ± 5, 75 ± 5, 85 ± 5, 95 ± 5, 125 ± 5 and 175 ± 5 Index (S/C). Levels of MMP-1, -2, -8, and -9 were determined using an enzyme-linked immunosorbent assay (ELISA).
Results. We established the quantitative amounts of gelatinases (MMP-2, MMP-9) and collagenases (MMP-1, MMP-8) in the blood plasma of donor groups depending on titers of anti-SARS-CoV-2 IgG. Here we have underlined the donor groups with maximum and minimum changes in MMP levels (among donor groups with titers of anti-SARS-CoV-2 IgG ≥ 10 ± 3 Index (S/C)) compared to the reference point (donor groups with titers of anti-SARS-CoV-2 IgG 0 Index (S/C)). The most statistically significant differences are the minimum (125 ± 5 Index (S/C)) and maximum (75 ± 5 Index (S/C)) levels of MMP-2 compared to the reference point; the maximum level of MMP-9 (10 ± 3 Index (S/C)) compared to the reference point; the maximum level of MMP-1 (175 ± 5 Index (S/C)) compared to the reference point; the minimum (10 ± 3 Index (S/C)) and maximum (65 ± 5 Index (S/C)) MMP-8 levels compared to the reference point. The results are presented in Figure 1.

Conclusion. We confirm the differences between MMP levels of reference point and donor groups with titers of anti-SARS-CoV-2 IgG ≥ 10 ± 3 Index (S/C). We underline that the presence of MMPs in blood plasma at various levels can lead to proteolysis destabilization. It may trigger metabolic dysfunctions and accompanying diseases in the post-COVID-19 period.